These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 30613154)
1. Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization. Liang R; Zhi Y; Zheng G; Zhang B; Zhu H; Wang M Onco Targets Ther; 2019; 12():157-168. PubMed ID: 30613154 [TBL] [Abstract][Full Text] [Related]
2. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
3. Identification of an eight-lncRNA prognostic model for breast cancer using WGCNA network analysis and a Cox‑proportional hazards model based on L1-penalized estimation. Liu Z; Li M; Hua Q; Li Y; Wang G Int J Mol Med; 2019 Oct; 44(4):1333-1343. PubMed ID: 31432096 [TBL] [Abstract][Full Text] [Related]
4. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma. Liang Q; Guan G; Li X; Wei C; Wu J; Cheng P; Wu A; Cheng W J Transl Med; 2020 Oct; 18(1):378. PubMed ID: 33028341 [TBL] [Abstract][Full Text] [Related]
5. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma. Gong Z; Hong F; Wang H; Zhang X; Chen J BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Wang Z; Ji X; Gao L; Guo X; Lian W; Deng K; Xing B Front Oncol; 2021; 11():553594. PubMed ID: 33747903 [TBL] [Abstract][Full Text] [Related]
7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel key lncRNAs involved in periodontitis by weighted gene co-expression network analysis. Jin SH; Zhou RH; Guan XY; Zhou JG; Liu JG J Periodontal Res; 2020 Jan; 55(1):96-106. PubMed ID: 31512745 [TBL] [Abstract][Full Text] [Related]
9. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis. Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y Front Genet; 2022; 13():760514. PubMed ID: 35273635 [No Abstract] [Full Text] [Related]
11. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
13. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer. Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701 [TBL] [Abstract][Full Text] [Related]
15. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction. Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H Front Oncol; 2020; 10():590352. PubMed ID: 33392085 [TBL] [Abstract][Full Text] [Related]
16. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma. Tao C; Luo H; Chen L; Li J; Zhu X; Huang K Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis. Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353 [TBL] [Abstract][Full Text] [Related]
18. LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer. Zhang Y; Li H; Zhang W; Che Y; Bai W; Huang G Mol Med Rep; 2018 Dec; 18(6):5579-5593. PubMed ID: 30365077 [TBL] [Abstract][Full Text] [Related]
19. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients. Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195 [TBL] [Abstract][Full Text] [Related]
20. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes. Li N; Zhan X EPMA J; 2020 Jun; 11(2):289-309. PubMed ID: 32549918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]